Prevalence of Different Subtypes of Renal Cell Carcinoma among Patients who have Undergone Nephrectomy; Statistics of a Referral Medical Center in Iran by Mohajer, Zahra et al.
Men’s Health Journal. 2021; 5(1): e10
ORIGINAL RESEARCH
Prevalence of Different Subtypes of Renal Cell Carci-
noma among Patients who have Undergone Nephrectomy;
Statistics of a Referral Medical Center in Iran
Zahra Mohajer1, Afshin Moradi2, Farzad Allameh3∗
1. MD; Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2. MD Professor of Pathology; Department of Pathology, Shohadae-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran,
Iran.
3. MD-MPH Assistant Professor of Urology; Men’s Health & Reproductive Health Research Center, Shahid Beheshti University of Medical
Sciences, Tehran, Iran.
Received: January 2021; Accepted: January 2021; Published online: February 2021
Abstract: Renal cell carcinoma (RCC) is the third most common genitourinary cancer in the world, and has the high-
est mortality rates among these types of cancers. In the present cross-sectional assessment, the prevalence of
RCC subtypes in a sample of Iranian patients diagnosed with RCC which have undergone nephrectomy surgery
between years 2014 to 2019 in a referral medical center has been investigated. We have studied 68 patients,
including 47 male and 21 female individuals with an average age of 55. The patients have been studied for de-
mographic and pathologic information such as age, sex, tumor size, tumor subtype, TNM staging, Fuhrman
nuclear grading, and other pathological information. The statistical analysis was done via SPSS software ver-
sion 21. Quantitative data were examined by T test and qualitative data were assessed by Chi square test. As
we observed in the results, the most common RCC subtype among these patients was clear cell 53%, followed
by papillary 22% and chromophobe 19%, emphasizing the higher rates of chromophobe RCC compared to the
statistics worldwide.
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1. Introduction
The most common cancer of the kidney is renal cell carci-
noma. It consists of different histologic subtypes (1, 2). RCC
has the highest mortality rates among all genitourinary can-
cers. It also ranks the third most common genitourinary can-
cer worldwide (3). If diagnosed in the early stages, this cancer
can be easily controlled by performing nephrectomy surgery.
Nevertheless, a low percentage of patients still remain at risk
of tumor recurrence (4). In addition, in patients with metas-
tasis (mRCC), it is usually considered as an incurable disease.
All RCC subtypes are different in prognosis and recurrence
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rates. According to a study performed on 290 patients by
Zhou H et al, results have shown that patients with clear cell-
papillary RCC have been diagnosed in early stages when the
tumor size is rather smaller. In addition, this particular sub-
type of RCC has not led to metastasis or cancer-specific death
in any of the patients (5).
In another investigation on 840 patients by Lau WK et al, a
significant difference in cancer-specific survival (CSS) and
metastasis-free survival (MFS) rates among different RCC
subtypes was observed. According to this research CSS and
MFS for clear cell RCC are 89.1% and 88.6% respectively, for
papillary RCC they are 95% and 93.8%, and for Chromophobe
RCC they are both 100%. This study proves that prognosis of
this cancer strongly depend on the RCC subtype (6).
The most common subtype of this cancer is clear cell (ccRCC)
and it is the mostly fatal subtype of renal cancer (7).
According to a study by Lucca I et al, men are more likely to
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be diagnosed with renal cell carcinoma than women. And
they usually have tumors with larger sizes and higher grade
and stage (8).
In an assessment, Nicodemus KK et al studied 41,836 women.
The results have shown that obesity and central accumula-
tion of adipose tissue can be a risk factor for renal cancer in
postmenopausal women (9).
Due to the inadequacy of statistics available on this matter
among Iranian population, we attempted to conduct this sur-
vey. The current study aims to assess the prevalence of dif-
ferent subtypes of RCC in patients undergone nephrectomy
surgery in Shohadae-Tajrish hospital during 2014 to 2019.
2. Materials and Methods
This cross-sectional study is conducted on a sample of 68 in-
dividuals (47 men and 21 women) with average age of 55 un-
dergone nephrectomy surgery in Shohadae-Tajrish hospital.
Subjects with clinically proven RCC were comprised the case
group of the current survey.
Demographic and pathologic characteristics were gathered
from all the participants. Pathologic characteristics like tu-
mor subtype, TNM staging, Fuhrman nuclear grade, tu-
mor size, neurolymphovascular invasion, necrosis, reactive
lymph nodes, and surgical margins were measured.
The statistical analysis was done via SPSS software version
21. Quantitative data were examined by T test. Moreover, Chi
square test was applied for qualitative variables.
3. Results
In this cross-sectional survey, 68 patients with average age of
55 were studied. The majority of the participants (approx-
imately 69%) were men. 59 patients (87%) had undergone
radical nephrectomy and the other 9 (13%) had undergone
partial nephrectomy. The frequency of Fuhrman grading be-
tween men included in this study were as follows: 4 men
(13%) presented grade I, 14 men (45%) grade II, 9 men (29%)
grade III, and 4 men (13%) presented grade IV. In 21 patients
of this group, (68%) necrosis was present, and in 10 patients
(32%) necrosis was not identified. Margins of the resected tis-
sue were tumor-free in 31 cases (67%) and in 15 cases (33%)
margins were involved by the tumor. In 18 cases (86%) no sar-
comatoid or rhabdoid feature were seen, but in 3 cases (14%)
at least one of these features were present. Also, in 17 cases
(61%) no reactive lymph node were detected in the resected
tissue, in 10 cases (35.7%) only one lymph node, and in 1 man
(3.3%) 3 lymph nodes were detected.
Women included almost 31% of the participants. Among all
the 21 women studied, majority of them were in the post-
menopausal age group. The frequency of Fuhrman grading
between women in this survey were as follows: 1 patient
(5.6%) presented grade I, 11 patients (61%) grade II, 5 pa-
tients (27.8%) grade III, and 1 patient (5.6%) presented grade
IV. In 6 cases of this group (40%) necrosis was present, and
in 9 cases (60%) necrosis was not identified. Margins of the
resected tissue were tumor-free in 15 cases (75%) and in 5
cases (25%) margins were involved by the tumor. In 9 cases
(90%) no sarcomatoid or rhabdoid feature were seen, but in 1
woman (10%) rhabdoid features were present. Also in 7 cases
(77.8%) no reactive lymph node were detected in the resected
tissue, in 1 woman (11.1%) only one lymph node, and in 1
woman (11.1%) 2 lymph nodes were detected.
Information about 64 patients who have shown clear cell,
papillary and chromophobe subtypes are presented in table
1. Among the other 4 patients, 2 of them were presented with
translocation carcinoma. Both were female with the average
age of 20. They both had grade II tumors, with mean size of
5.7 cm. In one of them, the margins were tumor-free and in
the other patient, they were involved by tumor. In addition,
in one of these patients no lymph node were identified, and
in the other one only 1 node was detected.
The patient with collecting duct carcinoma was a 57 year-old
man with mean tumor size of 4.5 cm. Necrosis was present
in the tissue resected, and margins were involved by tumor.
The last patient was a 38 year-old man with unclassified RCC,
with mean tumor size of 16 cm. The tumor was in grade
IV. Necrosis, sarcomatoid features and lymphovascular inva-
sions were present. The margins were also involved.
In general, 36 patients (53%) have presented the clear cell
subtype, followed by papillary in 15 patients (22%), chromo-
phobe in 13 patients (19%), translocation carcinoma in 2 pa-
tients (3%), collecting duct carcinoma in 1 patient (1.5%), and
unclassified RCC in 1 patient (1.5%). We can see the signifi-
cant difference between the frequencies of RCC subtypes in
our patients and the universal statistics, especially in chro-
mophobe RCC.
4. Discussion
To conclude, this research showed that among these 68
patients the most common subtypes are clear cell (53%),
followed by papillary (22%) and chromophobe (19%). Al-
together 5 patients (10.25%) presented grade I tumor, 25
patients (51%) grade II, 14 patients (28.5%) grade III, and 5
patients (10.25%) presented grade IV tumor. In 27 patients
(58.6%) necrosis was seen. In 46 patients (70%) margins of
the resected tissue were tumor-free. Neurolymphovascular
invasion was identified in 12 patients (21.4%). Sarcomatoid
features were present in 3 patients (9.6%) and rhabdoid
features were present in 2 patients (6.4%). Moreover, in 13
patients (35%) the tissue contained lymph nodes. We can
clearly observe that the male population diagnosed with this
cancer is almost three times as big as the female population
regardless of the RCC subtype.
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Table 1: Pathologic characteristics of study patients.
Characteristic Clear Cell (n=36) Papillary (n=15) Chromophobe (n=13)
Mean age (year) 55 61.3 53.3
Sex (M/F) M=25 (69.4%) M=10 (66.7%) M=10 (76.9%)
F=11 (30.6%) F=5 (33.3%) F=3 (23.1%)
Operation RN=31 (86.1%) RN=12 (80%) RN=12 (92.3%)
PN=5 (13.9%) PN=3 (20%) PN=1 (7.7%)
Mean tumor Size (cm) 6.5 7.4 10.1
Furman Grade G1=5 (14.7%) G1=0 G1=0
G2=17 (50%) G2=3 (42.8%) G2=3 (75%)
G3=9 (26.5%) G3=3 (42.8%) G3=1 (25%)
G4=3 (8.8%) G4=1 (14.4%) G4=0
Necrosis Present=10 (43.5%) Present=7 (77.8%) Present=6 (60%)
Not seen=13 (56.5%) Not seen=2 (22.2%) Not seen=4 (40%)
Margins Tumor free=26 (72.2%) Tumor free=10 (76.9%) Tumor free=9 (69.2%)
Involved=10 (27.8%) Involved=3 (23.1%) Involved=4 (30.8%)
NLV invasion Present=4 (18.2%) Present=4 (30.8%) Present=2 (20%)
Not seen=27 (81.8%) Not seen=9 (69.2%) Not seen=8 (80%)
Lymph nodes Present=4 (20%) Present=2 (25%) Present=5 (83.3%)
Not seen=16 (80%) Not seen=6 (75%) Not seen=1 (16.7%)
M: male; F: female; RN: radical nephrectomy; PN: partial nephrectomy; NLV: Neurolymphovascular invasion.
In an investigation on 3062 RCC patients by Leibovich BC
throughout 33 years, the results have shown that clear cell
RCC patients comprised 80.5% of all the patients. The per-
centage for papillary RCC and chromophobe RCC patients
were 14.3 and 5.2 respectively (10). However, we have found
that only 53% of our patients were diagnosed with clear cell
RCC, 22% with papillary and 19% with chromophobe RCC.
The ratio between the different subtypes of this cancer is
the main difference seen in our results. According to a study
conducted by Lipworth L et al on 1549 American patients
with RCC, there was a significant different in distribution of
RCC subtypes among white and black people. In comparison
with clear cell RCC, there was a higher chance patients with
papillary RCC were black and of male sex. On the contrary,
majority of the patients with chromophobe RCC were of
female sex. Overall, clear cell RCC subtype comprised 72.9%
among all the tumors. For papillary RCC and chromophobe
RCC the percentages were 15.7% and 5% respectively (11,
12).
In a survey conducted by Wu J et al on 2149 Chinese patients
with clear cell, papillary and chromophobe renal cell carci-
noma results show that compared to clear cell RCC patients,
there was a higher chance for chromophobe RCC patients to
be female, younger and to have larger tumor size (13).
According to this study, chromophobe RCC patients tend to
be younger and have tumors with larger diameters than clear
cell and papillary RCC patients; which matches the statistics
throughout the world. Nevertheless, as we can see in table
1 women comprise only 23.1% of the chromophobe RCC
patients; which is another difference we found, compared to
the statistics worldwide.
Regarding the fact that RCC does not respond well to neither
radiation therapy nor chemotherapy, there remains mainly
two modes of treatment: immunotherapy and nephrec-
tomy surgery which can be performed as radical or partial
nephrectomy (14, 15).
Nephron-sparing nephrectomy, also known as partial
nephrectomy, can prevent from renal insufficiency and
hypertension even in the elderly. It also may cause lower
other-cause mortality rates (16).
5. Conclusion
We recommend more extensive research be conducted on
the Iranian population to verify the statistics found in the
current study. In addition, on the assumption that the pat-
tern of distribution of the RCC subtypes worldwide is differ-
ent from Iran, further investigations must be performed.
6. Appendix
6.1. Acknowledgements
This research project has been approved by the ethics com-
mittee of Shahid Beheshti University of medical sciences.
(Ethics code: IR.SBMU.MSP.REC.1396.779)
6.2. Author contribution
All the authors have the same contribution.
6.3. Funding/Support
None.
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jmp.iums.ac.ir
Z. Mohajer et al. 4
6.4. Conflict of interest
All authors declare that there is no conflict of interest in this
study.
References
1. El Mouallem N, Smith SC, Paul AK, editors. Sarcomatoid
renal cell carcinoma: Biology and treatment advances.
Urologic Oncology: Seminars and Original Investigations;
2018: Elsevier.
2. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z.
2004 WHO classification of the renal tumors of the adults.
European urology. 2006;49(5):798-805.
3. Russo P, Jang TL, Pettus JA, Huang WC, Eggener SE,
O’Brien MF, et al. Survival rates after resection for localized
kidney cancer: 1989 to 2004. Cancer. 2008;113(1):84-96.
4. Cairns P. Renal cell carcinoma. Cancer biomarkers.
2011;9(1-6):461-73.
5. Zhou H, Zheng S, Truong LD, Ro JY, Ayala AG, Shen
SS. Clear cell papillary renal cell carcinoma is the fourth
most common histologic type of renal cell carcinoma in
290 consecutive nephrectomies for renal cell carcinoma.
Human pathology. 2014;45(1):59-64.
6. Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H.
Prognostic features of pathologic stage T1 renal cell carci-
noma after radical nephrectomy. Urology. 2002;59(4):532-
7.
7. Vijayalakshmi K, Shankar V, Bain RM, Nolley R, Sonn
GA, Kao CS, et al. Identification of diagnostic metabolic
signatures in clear cell renal cell carcinoma using mass
spectrometry imaging. International journal of cancer.
2020;147(1):256-65.
8. Lucca I, Klatte T, Fajkovic H, De Martino M, Shariat
SF. Gender differences in incidence and outcomes of
urothelial and kidney cancer. Nature Reviews Urology.
2015;12(10):585.
9. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of di-
etary, medical and lifestyle risk factors for incident kidney
cancer in postmenopausal women. International journal
of cancer. 2004;108(1):115-21.
10. Leibovich BC, Lohse CM, Crispen PL, Boorjian SA,
Thompson RH, Blute ML, et al. Histological subtype is an
independent predictor of outcome for patients with renal
cell carcinoma. The Journal of urology. 2010;183(4):1309-
16.
11. Lipworth L, Morgans AK, Edwards TL, Barocas DA,
Chang SS, Herrell SD, et al. Renal cell cancer histological
subtype distribution differs by race and sex. BJU interna-
tional. 2016;117(2):260-5.
12. Qi P, Tsivian M, Abern MR, Passoni NM, McGinley
KF, Polascik TJ, editors. Clinicopathological characteristics
and outcomes of surgically excised renal masses in African
Americans. Urologic Oncology: Seminars and Original In-
vestigations; 2014: Elsevier.
13. Wu J, Zhang P, Zhang G, Wang H, Gu W, Dai B, et al. Re-
nal cell carcinoma histological subtype distribution differs
by age, gender, and tumor size in coastal Chinese patients.
Oncotarget. 2017;8(42):71797.
14. Chin AI, Lam JS, Figlin RA, Belldegrun AS. Surveil-
lance strategies for renal cell carcinoma patients following
nephrectomy. Reviews in urology. 2006;8(1):1.
15. Lam JS, Belldegrun AS, Figlin RA. Advances in
immune-based therapies of renal cell carcinoma. Expert
review of anticancer therapy. 2004;4(6):1081-96.
16. Marchioni M, Preisser F, Bandini M, Nazzani S, Tian
Z, Kapoor A, et al. Comparison of partial versus radi-
cal nephrectomy effect on other-cause mortality, cancer-
specific mortality, and 30-day mortality in patients older
than 75 years. European urology focus. 2019;5(3):467-73.
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jmp.iums.ac.ir
